Colorectal Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Dec 1, 2004; 10(23): 3455-3458
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3455
Table 1 Selection of optimal concentration of PASODN
ClonesConcentration of PASODN (μmol/L)
012.551020
Mean64.751.541.024.711.18.4
Inhibitive rate (%)020.436.661.882.887.0
Table 2 Colony-forming efficiency in each group (mean ± SD)
PASODN(10 μmol/L)PMSODN(10 μmol/L)PBS(same volume)
Mean±SD41.2 ± 5.5196.3 ± 13.5202.8 ± 8.5
Efficiency (%)10.349.150.7
vs PASODNP < 0.01P < 0.01
Table 3 Variation of telomerase activity (mean ± SD)
GroupSAP
PASODN0.18 ± 0.12
PMSODN1.89 ± 0.24< 0.01
PBS1.98 ± 0.25< 0.01
Table 4 Effect of PASODN on LS-174T cell cycle
GroupsG0/G1G2/MS
Control49.9121.7928.30
PASODN53.2011.2535.55